The Efficacy of Heparin-boned Viabahn Endoprosthesis and Paclitaxel-coated Balloons for Complex Femoropopliteal Lesions - Trial NCT06124755
Access comprehensive clinical trial information for NCT06124755 through Pure Global AI's free database. This phase not specified trial is sponsored by RenJi Hospital and is currently Not yet recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
RenJi Hospital
Timeline & Enrollment
N/A
Dec 01, 2023
Aug 31, 2027
Primary Outcome
Primary patency,Freedom from a composite of Major adverse events (MAEs)
Summary
The purpose of this study is to evaluate the effectiveness of the Viabahn endoprosthesis for
 treating long femoropopliteal lesions (stenosis ≥ 25cm, occlusion ≥ 15cm) or recurrent
 in-stent restenosis compared to drug-coated balloons (DCB) with or without a bailout bare
 nitinol stent.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06124755
Device Trial